期刊文献+

确保上市医疗器械的安全性:器械和放射健康中心(CDRH)医疗器械上市后安全性监测计划(一) 被引量:5

下载PDF
导出
摘要 确保上市后医疗器械的安全性是各国监督管理部门应履行的职责。医疗器械在设计、功能方面的复杂性及风险特征决定了其监管方法的特异性。美国食品药品监督管理局下属的器械和放射健康中心(CDRH)负责医疗器械的上市前审批和上市后监管。相应地,CDRH通过上市前审批计划和上市后监测计划,使得医疗器械从设计、上市使用,到更新换代,组成了一个维护公众健康安全的统一体。本文为CDRH医疗器械上市后安全性监测计划的全部译文,包括CDRH上市后安全性监测框架,以及用来监测和评估与使用医疗器械有关的不良事件和风险的方法,并提出持续性改进措施。希望能为加强我国医疗器械监管,建立规范化、系统化的监管模式提供借鉴。
出处 《中国药物警戒》 2008年第1期8-11,51,共5页 Chinese Journal of Pharmacovigilance
  • 相关文献

参考文献13

  • 1[1]Amoore J,Ingram P.Learning from adverse incidents involving medical devices[J].Nurs Stand.2003,17(29):41-46.
  • 2[2]Gosbee J.Introduction to the human factors engineering series[J].Jt Comm J Qual Sar.2004,30(4):215-219.
  • 3[3]Gosbee J.Human factors engineering and patient safety[J].Qual Saf Health Care.2002,11(4):352-354.
  • 4[4]Gosbee J,Gardner-Bonneau D.The human factor.Systems work better when designed for the people whouse them[J].Healthc Inform.1998,15(2):141-142,144.
  • 5[5]Lin L,Vicente K J,Doyle D J.Patient safety,potential adverse drug events,and medical device design:ahuman factors engineering approach[J].J Biomed Inform.2001,34(4):274-284.
  • 6[6]Render M L.Research and redesign are safer than warnings and rules[J].Crit Care Med.2004,32(4):1074-1075.
  • 7[7]Welch D L.Human factors in the health care facility[J].Biomed Instrum Technol.1998,32(3):311-316.
  • 8[8]Reid M H,Sawyer D.The human factors implications of peritoneal dialysis:cycler overfill incidentreports[J].Int J Trauma Nurs.1999,5(2):68-71.
  • 9[9]Fairbanks R J,Caplan S.Poor interface design and lack of usability testing facilitate medical error[J].Jt Comm J Qual Saf.2004,30(10):579-584.
  • 10[10]Kaye R,Crowley J.Medical device use-safety:incorporating human factors engineering into risk management;identifying,understanding,and addressing use-related hazards.Guidance for Industry and FDA Premarket and Design Control Reviewers[EB/OL].2000[2006-1-18].Http://www.fda.gov/cdrh/humfac/1497.pdf.

同被引文献59

  • 1张素敏,曹立亚,曾光.世界各国医疗器械不良事件监测现状比较[J].中国医疗器械信息,2005,11(6):52-56. 被引量:29
  • 2FDA: Medical Device Reporting (MDR) [EB/OL]. (2014- 04-16). [2014 -06 -20].http ://www.fda.gov/MedicalDevices/ Safety/ReportaProblern/defauh.htm.
  • 3FDA. MAUDE Information Available to the Public [EB/OL]. ( 2014-03 -24).[2014-06-20].http://www.fda.gov/downloads/ Training/CDRHLearn/UCM234355.pdf.
  • 4FDA. Manufacturer and User Facility Device Experience Database - ( M AU DE ) [E B/OL]. (2014-03 - 12 ). [2014 -06- 20].http ://www:fda.gov/MedicalDevices/DeviceRegulationand Guidance/PostmarketRequirements/ReportingAdverseEvent s/ucm127891.htm.
  • 5FDA. MAUDE - Manufacturer and User Facility Device Experience (Simple Search) [EB/OL]. (2014 -05 -31 ). [2014-06-20]. http ://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfMAUDE/TextSearch.cfm.
  • 6FDA. MAUDE-Manufacturer and User Facility Device Experience (Advanced Search) [EB/OL]. (2014-05 -31 ). [2014-06-20]. http ://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfMAUDE/Search.cfm.
  • 7FDA. Mandatory Reporting Requirements: Manufacturers, Importers and Device User Facilities [EB/OL]. (2014-06- 13). [2014 -06 -20]. http ://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/PostmarketRequirements/Re portingAdverseEvents/ucm2005737.htm.
  • 8SAS. IMPORT: Base SAS(R) 9.3 Procedures Guide, Second Edition[EB/OL].(2014-05-06). [2014-06-20]. http://support. sas.com/documentation/cdl/en/proc/65145/HTML/default/viewer.htm#n I qn5sclnu219dn 1 w61 ifw8wqhts.htm.
  • 9FDA. Overview of Regulatory Requirements: Medical Devices [EB/OL]. (2014-06-25). [2014 -06-25]. http ://www.fda. gov/downloads/Training/CDRHLearn/UCM400786.pdf.
  • 10FDA. CFR - Code of Federal Regulations Title 21[EB/OL]. (2013-06-01).[2014-06-20}.http : //www.accessdata.fda. gov/scripts/cdrhlcfdocs/cfcfr/cfrsearch.cfm.

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部